A functional link between T-type calcium channels and mu-opioid receptor expression in adult primary sensory neurons

J Neurochem. 2009 May;109(3):867-78. doi: 10.1111/j.1471-4159.2009.06014.x. Epub 2009 Feb 24.

Abstract

The mu-opioid receptor agonists have a preferential effect on nociception in adults but their analgesic effect is less selective in neonates. Here we presented our finding that the mu-opioid receptor agonists had no effect on high voltage-activated Ca(2+) channels (HVACCs) in adult dorsal root ganglion (DRG) neurons that exhibited a prominent T-type Ca(2+) current. We also determined the mechanisms underlying the mu-opioid agonists' lack of effect on HVACCs in these neurons. The mu-opioid agonist [D-Ala(2),N-Me-Phe(4),Gly-ol(5)]-enkephalin (DAMGO), morphine, and morphine 6-beta-D-glucuronide had no effect on either T-type or HVACC currents despite the presence of a large N-type Ca(2+) current in neurons with T-type Ca(2+) currents. DAMGO still had no effect on HVACC currents when T-type Ca(2+) channels were blocked in these neurons. However, intracellular dialysis of GTP-gamma-S to activate G proteins significantly attenuated HVACC currents. DRG neurons with T-type Ca(2+) currents showed little responses to capsaicin. Single-cell RT-PCR analysis revealed that the mu-opioid receptor mRNA was present only in adult DRG neurons lacking prominent T-type Ca(2+) currents. In the neonatal DRG, DAMGO inhibited HVACC currents in 31% neurons with T-type Ca(2+) currents. The mu-opioid receptor mRNA was detected in all neurons without T-type Ca(2+) currents and also in 28.6% of neurons with T-type Ca(2+) currents in the neonatal DRG. Our study provides novel information that adult DRG neurons with prominent T-type Ca(2+) currents do not express mu-opioid receptors. Expression of T-type Ca(2+) (Ca(V)3.2) channels and mu-opioid receptors may be developmentally co-regulated as some DRG neurons differentiate toward becoming nociceptive neurons.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Animals
  • Baclofen / pharmacology
  • Biophysics
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, T-Type / genetics
  • Calcium Channels, T-Type / metabolism*
  • Capsaicin / pharmacology
  • Cells, Cultured
  • Drug Interactions
  • Electric Stimulation / methods
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • GABA Agonists / pharmacology
  • Ganglia, Spinal / cytology
  • Gene Expression / drug effects
  • Gene Expression / physiology*
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Lectins / metabolism
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Patch-Clamp Techniques / methods
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, mu / agonists
  • Receptors, Opioid, mu / genetics
  • Receptors, Opioid, mu / metabolism*
  • Sensory Receptor Cells / drug effects
  • Sensory Receptor Cells / metabolism*
  • omega-Conotoxin GVIA / pharmacology

Substances

  • Analgesics, Opioid
  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • GABA Agonists
  • Lectins
  • Receptors, Opioid, mu
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • omega-Conotoxin GVIA
  • Baclofen
  • Capsaicin